1Uhl W, Muller C, Buchler MW. Definition of predictors of a complicated course in acute pancreatitis [ J]. Langenbecks Arch Chir Suppl Kongressbd, 1998,115:427.
2Zazzo JF. Nutrition in acute pancreatitis[J]. Schweiz Med Wochenschr,1999,129(43) : 1617.
3Kingsnorth AN. Platclct-activating factor [J]. Scand J Gastroentcrol,1996,219(Suppl) :28.
4Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood memnudear cells from patients with acute pancreatitis[J]. Br J Sang, 1996,83(8) : 1071.
5Johnson CD. Platelet-atalvafing factor and platelet-ataivating factor antagonists in acute pancreatitis[J]. Dis Surg,1999,16(2):93.
6Lane JS, Todd KE, Gloat B, et al. Platelet activating factor antagonism reduces the systermic inflammatory response in a muringe model of acute pancreatitis[J]. J Stag Res,2OO1,99(2) :365.
7Liu Q, Djuricin G, Rossi H, et al. The effect of lexipafant on bacterial translocation in acute nerotizing pancreatitis in rata[J]. Am Surg,1999,65(7) :611.
8Andersson R, Wang X, Sun Z, et al. Effect of a platdet-activating factor antagonist on pancreatic-associated gut barrier dyfunction in rats [J]. Pancreas, 1998, 17(2) : 107.
9Wang X, Sun Z, Borjesson A, et al. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis[J]. Int J Pancreatol, 1999,25(1) :45.
10McKay CJ, Curran F, Sharples C, et al. Prospective placebo-controlled randomized trial of lexipafnat in predicted seveee acute pancreatits[J]. Br J Surg, 1997,84(9) : 1239.
3FAN G J, KIM S, HAN B H, et al. Glyceroglycolipids, a novel class of platelet-activating factor antagonists from Kalimeris indica [J]. Phytochem Lett, 2008,1 (4) :207 -210.
6CATENI C, FALSONE G, ZILIC J, et al. Glyceroglycolipids from Euphorbia nicaeensis All. with antiinflamatory activity [ J ]. ARKIVOC, 2004, ( v ) : 54 -65.
7TERASHITA Z, IMURA Y, TAKATANI M, et al. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo[ J ]. J Pharmacol Exp Ther, 1987,242( 1 ) :263 - 268.
8KUIPERS B, VAN DER POLL T, LEVI M, et al. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees[ J ]. Eur J Immunol, 1994,152 ( 5 ) :2438 - 2446.
9ABE Y, KASUYA H, SUZUKI S, et al. Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model [ J ]. Eur J Pharmacol ,2002,455 ( 2 ) : 127 - 133.
10COY-BARRERA E D, CUCA-SUAREZ L E, SEFKOW M. PAF-antagonistic bicyclo [ 3.2. 1 ] octanoid neolignans from leaves of Ocotea macrophylla Kunth. ( Lauraceae ) [J].Phytochemistry, 2009,70 : 1309 - 1314.
